First Personal Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-4
Closed -$2K 472
2019
Q4
$2K Sell
4
-60
-94% -$20.2K ﹤0.01% 379
2019
Q3
$18K Hold
64
0.01% 331
2019
Q2
$20K Buy
64
+4
+7% +$1.33K 0.01% 406
2019
Q1
$25K Hold
60
0.01% 372
2018
Q4
$22K Sell
60
-3
-5% -$1.1K 0.01% 367
2018
Q3
$25K Buy
63
+40
+174% +$15.2K 0.01% 380
2018
Q2
$8K Sell
23
-25
-52% -$7.82K ﹤0.01% 523
2018
Q1
$17K Buy
48
+3
+7% +$1.04K ﹤0.01% 664
2017
Q4
$17K Hold
45
﹤0.01% 680
2017
Q3
$20K Sell
45
-10
-18% -$4.76K ﹤0.01% 590
2017
Q2
$27K Buy
55
+10
+22% +$4.38K 0.01% 528
2017
Q1
$17K Sell
45
-16
-26% -$5.93K ﹤0.01% 594
2016
Q4
$23K Buy
61
+45
+281% +$17.1K 0.01% 529
2016
Q3
$6K Buy
+16
New +$6.42K ﹤0.01% 680

Other funds holding REGN

First Personal Financial Services's REGN Position: Q1 2020 in Review

First Personal Financial Services sold out of Regeneron Pharmaceuticals (REGN) in Q1 2020, closing a stake of 4 shares — an estimated $2K sold.

First Personal Financial Services first reported a position in REGN in Q3 2016 and held it in 14 quarters. The position peaked at $27K in Q2 2017. 816 funds tracked by Wall St. Rank hold REGN as of Q1 2020.

  • First Personal Financial Services reported no remaining Regeneron Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • First Personal Financial Services sold 4 Regeneron Pharmaceuticals shares in Q1 2020, an estimated $2K.
  • First Personal Financial Services first reported a position in Regeneron Pharmaceuticals in Q3 2016 and held it in 14 quarters.
  • First Personal Financial Services's Regeneron Pharmaceuticals position peaked at $27K in Q2 2017.
  • 816 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2020.

Based on First Personal Financial Services's 13F filing for Q1 2020, filed 22 Apr 2020.